Adults with arterial stiffness show a distinct immune remodeling pattern driven by CD4+ T cell dysfunction that differs from typical aging-related immune decline. This paradoxical expansion of dysfunctional T cell clones suggests a disease-specific immune pathway in early vascular aging, detectable through peripheral immune profiling before clinical cardiovascular manifestations appear.
Key Points
- CD4+ T cell dysfunction precedes clinical arterial stiffness in disease-free adults
- Vascular immune remodeling produces increased TCR diversity despite chronic activation
- Machine learning identifies high arterial stiffness risk with 81.7% accuracy from immune markers
Longevity Analysis
The immune system's role in vascular function operates through mechanisms that diverge from conventional aging models. Rather than the typical T cell exhaustion seen in older adults, arterial stiffness correlates with a paradoxical expansion of dysfunctional CD4+ clones that maintain proliferative capacity yet fail to mount effective responses. This reframing matters because it suggests interventions targeting T cell dysfunction could address vascular stiffening before atherosclerosis develops, and because peripheral immune profiling may serve as an earlier biomarker of vascular compromise than current screening methods. Understanding how immune dysregulation mechanically impairs arterial compliance—independent of classical immunosenescence—opens pathways for immune-specific prevention in cardiovascular disease.
Original published by Wiley Aging Cell, by Yu Miao, Bangwei Chen, Changqing Zeng, Xiaofen Wu, Minglei Yang, Cuntai Zhang, Jianguo Zhang, Yutao Du, Tao Li, Lei Ruan .